ALT Q1 2018 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4,938-99.4% YoY

Gross Profit

-$6M-116282.6% margin

Operating Income

-$6M-121396.5% margin

Net Income

-$3M-64267.7% margin

EPS (Diluted)

$-4.69

QoQ Revenue Growth

-99.8%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$356,709

Balance Sheet

Total Assets

$61M

Total Liabilities

$14M

Stockholders' Equity

$46M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4,938	$804,071	-99.4%
Gross Profit	-$6M	-$2M	-189.7%
Operating Income	-$6M	-$3M	-88.3%
Net Income	-$3M	-$2M	-44.4%